Avalon GloboCare Corp. (ALBT) Balance Sheet

The contraction in total assets suggests that the firm is consuming its resource base to fund ongoing operations in the absence of revenue. This downward trajectory indicates that the balance sheet is becoming increasingly fragile, leaving little room for error as the company attempts to advance its clinical pipeline.

A current ratio consistently below 1.0 suggests that the company lacks the liquid assets necessary to meet its short-term liabilities, placing it in a state of chronic financial distress. Investors should monitor this liquidity gap closely, as it likely necessitates further dilutive financing to prevent a total cessation of research activities.

The deep deficit in retained earnings indicates that the company has failed to generate profitable growth from its historical investments, forcing a reliance on external capital to sustain its existence. This persistent negative equity trend suggests that the firm's capital structure is heavily skewed toward funding past failures rather than future value creation.